RED ROBIN GOURMET BURGERS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data RED ROBIN GOURMET BURGERS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,303	1,388	1,339	1,315	869	1,162	1,266	1,303	1,249	1,210
Cost of revenue	298	320	314
Gross profit	1,005	1,067	1,025
Selling, general and administrative	145	157	146	156	107	123	137	124	118
Selling and marketing	37.6	48	44.3	44.3	24.9	34.3	35.7	21.6	23.5	18.7
General and administrative								89.4	81.7	76.3
Operating income	11.6	39	-10.5	-13.1	-275	-37.1	-57.5	4.54	-53.1	2.79
Interest expense			10.7	10.2	10.2	14.2	20.6	26.6	25.3	26
Other non-operating income	-6.78	-10	-10.9	-9.11	-154	-16.1	-39	2.66	-33.8	-10.5
Pre-tax income	4.79	29	-21.4	-22.2	-284	-50.6	-78.1	-20.9	-77.6	-23
Income tax	-6.94	-1	-15	-14.3	-7.48	-0.15	0.75	0.31	-0.09	0.26
Net income	11.7	30	-6.42	-7.9	-276	-50.4	-78.9	-21.2	-77.5	-23.3
EBITDA	98.3	132	84.9	78.7	-188	46.3	18.7	70.7	4.65	53.9
EPS, basic	0.88	2.33	-0.49	-0.61	-19.29	-3.22	-4.98	-1.34	-4.93	-1.31
EPS, diluted	0.87	2.31	-0.49	-0.61	-19.29	-3.22	-4.98	-1.34	-4.93	-1.31
Shares, basic (weighted)	13.3	12.9	13	13	14.3	15.7	15.8	15.8	15.7	17.8
Shares, diluted (weighted)	13.5	13	13	13	14.3	15.7	15.8	15.8	15.7	17.8

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	11.7	17.7	18.6	30	16.1	22.8	48.8	23.6	30.7	19.9
Receivables	24.2	26.5	25	22.4	16.5	21.4	22	21.6	19.7	19.4
Inventory	29.9	29.6	27.4	26.4	23.8	25.2	26.4	26.8	26.7	25.7
Other current assets	27	31	27.6	21.3	13.8	17	12.9	11.8	13.6	14.2
Total current assets	92.8	105	98.5	105	86.9	102	120	91.8	99.4	88.9
Property, plant and equipment	656	638	565	518	427	386	319	261	181	158
Lease right-of-use assets				419	416	401	361	362	332	296
Goodwill	95.9	97	95.8	96.4	0
Intangible assets	42.3	38.3	34.6	30	24.7	21.3	17.7	15.5	11.1	9.16
Other non-current assets	31.1	32.4	49.8	61.5	20.2	18.4	14.9	11.8	13.7	9.07
Total assets	919	911	844	1,238	975	929	832	742	641	564
Accounts payable	26.6	35.3	39	33	20.2	32.5	39.3	27.7	29.8	31.4
Accrued liabilities	29.5	36.3	38.1	29.4	40.7	45.5	49.5	46.2	42.9	46.8
Deferred revenue	50.2	55.9	55.4	54.2	50.1	54.2	46.9	36.1	27.1	27.3
Short-term debt	0.66	0.74	0	0	9.69	9.69	3.38	0
Total current liabilities	141	160	171	195	203	223	220	186	190	199
Long-term debt	347	277	193	207		167	203	183	182	165
Lease liabilities				457	454	435	393	383	346	300
Other non-current liabilities	9.87	11.3	11.5	10.2	36.2	26.3	13.8	10	8.76	6.45
Total liabilities	570	523	461	877	854	852	830	762	726	670
Total debt	348	277	193	207	161	167	214	189	189	170
Paid-in capital	208	211	213	214	243	243	239	230	234	213
Retained earnings	353	383	376	353	77.2	27.2	-54.2	-75.4	-153	-176
Treasury stock	-208	-202	-202	-202	-200	-193	-183	-175	-165	-143
Other comprehensive income	-5.01	-3.57	-4.8	-4.37	-0	0	-0.03	-0.02	-0.06	-0.06
Shareholders' equity	348	387	383	361	119	74.5	1.79	-20.4	-84.3	-106
Total equity	348	387	383	361	119	74.5	1.79	-20.4	-84.3	-106
Total liabilities and equity	919	911	844	1,238	975	929	832	742	641	564
Shares outstanding	12.8	13	13	12.9	15.5	15.7	15.9	15.5	17.4	18

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	11.7	30	-6.42	-7.9	-276	-50.4	-78.9	-21.2	-77.5	-23.3
Depreciation and amortization	86.7	92.5	95.4	91.8	87.6	83.4	76.2	66.2	57.7	51.1
Stock-based compensation	4.55	4.79	4.05	3.34	4.33	6.62	6.29	6.93	6.96	1.47
Deferred income tax	-11.9	-6.48	-18.6	-9.59	51.5	0	0	0	0	0
Change in receivables	6.8	-0.61	-2.92	2.77	5.6	-4.92	-0.03	0.4	1.9	0.25
Change in inventory	-1.22	0.42	0.83	0.16	2.24	-1.93	-1.81	-0.28	-0.22	0.13
Change in payables	-22.4	21	5.69	-15.5	-9.57	19.4	11.7	-9.84	3.44	7.75
Cash from operations	99	157	126	57.9	20.2	47.3	35.5	-1.16	7.05	37
Capital expenditures					-22.1	-42.3	-38.2	-49.4	-26	-30.8
Acquisitions	-40	0	0			0	0	-3.53	0	0
Cash from investing	-199	-83.3	-49.8	-57	-21.4	-42.2	-29.6	8.23	-1.75	-24.6
Debt issued	367	187	216	274	211	193	297	0
Stock issued			0	0	28.7	0	0	0	7.09
Share buybacks	-46.1	0	-1.47	-3.45	-1.64	0	0	-9.96	0	0
Cash from financing	89.3	-67.9	-74.3	9.68	-11.7	1.56	29.5	-33.7	2.54	-22.3
Exchange rate effect	0.12	0.59	-1.31	0.91	-1.07	0.02	-0.04	0	0	0
Net change in cash	-11	0.59	0.86	11.5	-13.9	6.63	35.5	-26.6	7.84	-9.86
Free cash flow					-1.9	5.03	-2.63	-50.6	-19	6.22
Interest paid	6.46	10.4	10	9.75	9.87	10.5	16.1	24.1	22.7	23.1
Income taxes paid	4.65	4	2.49	3.24		-0.96	-14.6	0.45	0.08	-0.03

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $7.25 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	0.2%	Operating income / revenue.
EBITDA margin	4.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-1.9%	Pre-tax income / revenue.
Net margin	-1.9%	Net income / revenue.
FCF margin	0.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	3.1%	Cash from operations / revenue.
Return on assets (ROA)	-3.9%	Net income / average total assets.
Return on invested capital (ROIC)	3.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.5%	Capital expenditures / revenue.
D&A / revenue	4.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-3.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	1,060.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	42.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	425.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	1.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	12.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-12.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-12.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-10.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	13.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	3.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	4.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.45x	Current assets / current liabilities.
Quick ratio	0.20x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.10x	(Cash + short-term investments) / current liabilities.
Debt / assets	30.2%	Total debt / total assets.
Liabilities / assets	118.9%	Total liabilities / total assets.
Net debt	$150.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.79x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	0.11x	Operating income / interest expense.
Working capital	-$109.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	1.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$115.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	2.01x	Revenue / average total assets.
Fixed asset turnover	7.13x	Revenue / average property, plant and equipment.
Receivables turnover	61.9x	Revenue / average receivables.
Days sales outstanding	6 days	365 x average receivables / revenue.
Capex / operating cash flow	83.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.31	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$1.31	Net income per basic share, as reported (split-adjusted).
Revenue per share	$68.03	Revenue / diluted weighted shares.
FCF per share	$0.35	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.08	Cash from operations / diluted weighted shares.
Book value per share	-$5.91	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$6.41	Tangible book value / shares outstanding.
Cash per share	$1.11	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	0.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$137.1M	Share price x shares outstanding.
Enterprise value	$287.3M	Market cap + total debt - cash - short-term investments.
P/S	0.11x	Market cap / revenue.
P/FCF	22.0x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	3.70x	Market cap / cash from operations, when positive.
EV/Sales	0.24x	Enterprise value / revenue.
EV/EBIT	103x	Enterprise value / operating income, when both are positive.
EV/EBITDA	5.33x	Enterprise value / EBITDA, when both are positive.
EV/FCF	46.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.5%	Free cash flow / market cap.
Earnings yield	-17.0%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.0%	(Dividends paid + share buybacks) / market cap.

What was RED ROBIN GOURMET BURGERS INC's revenue in fiscal 2025?

RED ROBIN GOURMET BURGERS INC reported revenue of $1.21B for fiscal 2025, 3.1% lower than the year before.

Was RED ROBIN GOURMET BURGERS INC profitable in fiscal 2025?

No. It reported a net loss of $23.3M.

How much free cash flow did RED ROBIN GOURMET BURGERS INC generate in fiscal 2025?

Cash from operations of $37.0M minus capital expenditures of $30.8M left free cash flow of $6.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to RED ROBIN GOURMET BURGERS INC